CY A. STEIN, M.D., Ph.D.; WAYNE SAVILLE, B.S.; ROBERT YARCHOAN, M.D.; S. BRODER, M.D.; EDWARD P. GELMANN, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Suramin (Germanin, Bayer 205), the sodium salt of a sulfonated naphthyl polyurea, was initially introduced as a treatment for African trypanosomiasis. More recently, it has undergone clinical testing in patients with the acquired immunodeficiency syndrome (AIDS) (1) because of its ability to block the infectivity and cytopathic effect of the human T-lymphotropic virus type III/lymphadenopathy associated virus (2). We report an important apparent toxicity of suramin and describe the case of a patient with AIDS who developed profound hypoadrenalism after treatment with the drug.
A 35-year-old white man with AIDS and Kaposi's sarcoma since 1982 had received
STEIN CA, SAVILLE W, YARCHOAN R, et al. Suramin and Function of the Adrenal Cortex. Ann Intern Med. 1986;104:286–287. doi: 10.7326/0003-4819-104-2-286_2
Download citation file:
Published: Ann Intern Med. 1986;104(2):286-287.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use